Results 141 to 150 of about 938,592 (268)
HCV RNA Quantification by a Domestic Commercial Assay: A Case Study among People Who Inject Drugs in Vietnam. [PDF]
Nhu QBT +19 more
europepmc +1 more source
Tükürükten ayrıştırılan HCV antikorları ile Serum HCV-RNA arasındaki korelasyonun belirlenmesi
Amaç: Tükürükte Hepatit C virusuna(HCV) karşı bulunan antikorlar ile kandaki HCV-RNA ve antikorları arasındaki ilişkiyi araştırmak ve epidemiyolojik çalışmalar ön planda olmak üzere saha çalışmalarında bu yöntemin kullanılabilirliğini saptamaktır.Gereç ...
OYA ÖZLEM EREN KUTSOYLU
core
ABSTRACT People with HIV (PWH) are living longer, but contemporary data on non–AIDS‐defining cancers (NADCs) in Italy remain limited. We assessed incident cancers in a retrospective cohort of PWH in Milan, Italy, between January 2000 and December 2023. Follow‐up was grouped into 2000–2007, 2008–2015, and 2016–2023. Incidence rates (IRs) were calculated
Giacomo Pozza +14 more
wiley +1 more source
HCV Core-antigen Assay as an Effective Alternative to HCV RNA Quantification in Patients With Hepatitis C. [PDF]
Vieira R +5 more
europepmc +1 more source
ABSTRACT Aim Metabolic syndrome (MetS) is a known risk factor for hepatocellular carcinoma (HCC), but the impact of cumulative MetS burden and changes in MetS status over time remains unclear. This study aimed to assess these associations using a large‐scale Japanese health dataset.
Yutaka Yata +9 more
wiley +1 more source
An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA. [PDF]
Hansoongnern P +9 more
europepmc +1 more source
ABSTRACT Background In a randomized, blinded, dual center study across two European primate research facilities, we evaluated the immunogenicity and protective efficacy of a DNA prime—oropharyngeal adenoviral boost vaccination strategy against respiratory syncytial virus (RSV).
Matthias Tenbusch +15 more
wiley +1 more source
Recognition of 7 genes signature (Cirrhosis Risk Score) in the diagnosed non-responders to DAAs therapy by intra-PBMCs nested HCV RNA PCR. [PDF]
Galal AGM +5 more
europepmc +1 more source
ABSTRACT Treatment indication for chronic hepatitis B (CHB) varies across clinical guidelines. This study evaluated treatment eligibility and uptake in a large Australian cohort of people with CHB. The REACH‐B study recruited people with CHB managed through a national network of healthcare services.
Behzad Hajarizadeh +28 more
wiley +1 more source
Assessment of HCV-RNA test results and access rates to antiviral treatment in patients with anti-HCV positivity-a 10-year analysis. [PDF]
Türkoğlu E, Parlak Z, Barut HŞ.
europepmc +1 more source

